Cyclosporine therapy advanced Langerhans cell histiocytosis evidence Langerhans histiocytosis LCH nonmalignant disorder immune regulation cyclosporine mg/kg/d young children advanced multisystem LCH patients partial responses months therapy complete resolution organ dysfunction regression majority lesions Complete responses nontoxic chemotherapy ie prednisone vinblastine Toxicity cyclosporine mild reversible elevations serum creatinine blood urea nitrogen results evaluation cyclosporine treatment patients advanced LCH 